Johnson & Johnson vs Keysight Technologies Inc — how do they compare? Johnson & Johnson trades at $250.8 (market cap $598.96B), while Keysight Technologies Inc trades at $329.98 (market cap $53.68B). The key difference: Johnson & Johnson is far larger — about 11.2× Keysight Technologies Inc's market cap, and Johnson & Johnson pays a 2.15% dividend while Keysight Technologies Inc pays none. Which is the better fit depends on your goals.
| JNJ | KEYS | |
|---|---|---|
Market Cap | $598.96B | $53.68B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $373.34 |
52-Week Low | $164.36 | $158.51 |
Enterprise Value | $631.90B | $54.03B |
Dividend Yield | 2.15% | — |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →